TrialThe Lancet. Microbe2022

Effectiveness of pyronaridine-artesunate against Plasmodium malariae, Plasmodium ovale spp, and mixed-Plasmodium infections: a post-hoc analysis of the CANTAM-Pyramax trial.

Mirjam Groger et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.